Needle-free injectors for mass administration of fractional dose inactivated poliovirus vaccine in Karachi, Pakistan: A survey of caregiver and vaccinator acceptability.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
18 02 2020
Historique:
received: 10 10 2019
revised: 22 12 2019
accepted: 25 12 2019
pubmed: 28 1 2020
medline: 18 3 2021
entrez: 28 1 2020
Statut: ppublish

Résumé

The first large-scale vaccination campaign using needle-free jet injectors to administer fractional doses of inactivated poliovirus vaccine (fIPV) was conducted in Karachi, Pakistan, in February 2019. Data on acceptability of jet injectors were collected from 610 vaccinators and 4898 caregivers during the first four days of the campaign. Of those with prior needle and syringe experience, both vaccinators and caregivers expressed a strong preference for jet injectors (578/592 [97.6%] and 4792/4813 [99.6%], respectively), citing ease of use, appearance, and child's response to vaccination. Among caregivers, 4638 (94.7%) stated they would be more likely to bring their child for vaccination in a future campaign that used jet injectors. Mean vaccine coverage among towns administering fIPV was 98.7% - an increase by 18.4% over the preceding campaign involving full-dose IPV. Our findings demonstrate the strong acceptability of fIPV jet injectors and highlight the potential value of this method in future mass campaigns.

Identifiants

pubmed: 31983581
pii: S0264-410X(19)31723-2
doi: 10.1016/j.vaccine.2019.12.059
pii:
doi:

Substances chimiques

Poliovirus Vaccine, Inactivated 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1893-1898

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Catherine Daly (C)

World Health Organization (WHO), Islamabad, Pakistan. Electronic address: dalyc@who.int.

Natalia A Molodecky (NA)

World Health Organization (WHO), Islamabad, Pakistan; National Emergency Operations Centre for Polio Eradication, Islamabad, Pakistan.

Meghana Sreevatsava (M)

World Health Organization (WHO), Islamabad, Pakistan.

Asalif D Belayneh (AD)

World Health Organization (WHO), Sindh, Pakistan.

Shoukat A Chandio (SA)

United Nations Children's Fund (UNICEF), Sindh, Pakistan.

Jeff Partridge (J)

Bill & Melinda Gates Foundation, Seattle, USA.

Ahmed Shaikh (A)

Bill & Melinda Gates Foundation, Sindh, Pakistan.

Mumtaz Laghari (M)

National Stop Transmission of Polio (N-STOP) Program, Pakistan.

John Agbor (J)

United Nations Children's Fund (UNICEF), Islamabad, Pakistan.

Rana M Safdar (RM)

Ministry of National Health Services, Regulations and Coordination, Islamabad, Pakistan.

Umar Farooq Bullo (UF)

Ministry of National Health Services, Regulations and Coordination, Sindh, Pakistan.

Safi M Malik (SM)

Ministry of National Health Services, Regulations and Coordination, Islamabad, Pakistan.

Abdirahman Mahamud (A)

World Health Organization (WHO), Islamabad, Pakistan; National Emergency Operations Centre for Polio Eradication, Islamabad, Pakistan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH